CD8+ chronic lymphocytic leukemia: An extensive characterization of a bizarre hybrid neoplasia

European Journal of Haematology

Volumn 71, Issue 3, 2003, Pages 224-230

  Richaud Patin, Y ^a   Piedras, J ^a   Carrillo Maravilla, E ^a   Lopez Karpovitch X ^a   Llorente, Luis ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Chemokines; Chronic lymphocytic leukemia; Cytokines; Cytotoxic enzymes; Immunophenotype

Indexed keywords

CD40 LIGAND; CD56 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR4; CYTOKINE; GLYCOPROTEIN P 15095; GRANZYME A; GRANZYME B; MESSENGER RNA; PERFORIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW BIOPSY; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; CYTOTOXIC T LYMPHOCYTE; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; NATURAL KILLER CELL; PRIORITY JOURNAL; SYMPTOM; SYNCOPE; TH1 CELL; TH2 CELL;

ANTIGENS, CD11C; ANTIGENS, CD56; ANTIGENS, CD8; CD40 LIGAND; CYTOKINES; FEMALE; HUMANS; IMMUNOPHENOTYPING; INTERLEUKINS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; MIDDLE AGED; P-GLYCOPROTEIN; RECEPTORS, CHEMOKINE; RNA, MESSENGER;

EID: 0041833329     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0609.2003.00121.x     Document Type: Article

References (30)

1. KUREC AS, THREATTE CA, GOTTLIEB AJ, SMITH JR, ANDERSON J, DAVEY FR. Immunophenotypic classification of chronic lymphocytic leukaemia (CLL). Br J Haematol 1992;81:45-51.
2. GREAVES MF, CHAN LC, FURLEY AJW, WATT SM, MOLGAARD HV. Lineage promiscuity in hemopoietic differentiation and leukemia. Blood 1986;67:1-11.
3. ISLAM A, VLADUTIU AO, DONAHUE T, AKHTER S, SANDS AM, AMBRUS JL. CD8 expression on B cells in chronic lymphocytic leukemia. A case report and review of the literature. Arch Pathol Lab Med 2000;124:1361-1363.
4. RAI KR, SAWITSKY A, CRONKITE EP, CHANANA AD, LEVY RN, PASTERNAK BS. Clinical staging of chronic lymphocytic leukemia. Blood 1975;46:219-234.
5. BINET JL, AUQUIER A, DIGHIERO G, et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981;48:198-206.
6. MASON D, ANDRÉ P, BENSUSSAN A, et al. CD antigens 2001: aims and results of HLDA Workshops. Stem Cells 2001;19:556-562.
7. SCHATTNER EJ, MASCARENHAS J, REYFMAN I, KOSHY M, WOO C, FRIEDMAN SM, CROW MK. Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity. Blood 1998;91:2689-2697.
8. HOFFBRAND AV, PANAYIOTIDIS P, REITTIE J, GANESHAGURU K. Autocrine and paracrine growth loops in chronic lymphocytic leukemia. Semin Hematol 1993;30:306-317.
9. PISTOIA V. Production of cytokines by human B cells in health and disease. Immunol Today 1997;18:343-350.
10. BUSCHLE M, CAMPANA D, CARDING SR, RICHARD C, HOFFBRAND AV, BRENNER MK. Interferon-γ inhibits apoptotic cell death in B-cell chronic lymphocytic leukemia. J Exp Med 1993;177:213-218.
11. DANCESCU M, RUBIO-TRUJILLO M, BIRON G, BRON D, DELESPESSE G, SARFATI M. Interleukin-4 protects chronic lymphocytic leukemia from death by apoptosis and upregulates Bcl-2 expression. J Exp Med 1992;176:1319-1326.
12. MAINOU-FOWLER T, COPPLESTONE JA, PRENTICE AG. Effect of interleukins on the proliferation and survival of B cell chronic lymphocytic leukemia cells. J Clin Pathol 1995;48:482-487.
13. BANNERJI R, BYRD JC. Update on the biology of chronic lymphocytic leukemia. Curr Opin Oncol 2000;12:22-29.
14. CORDINGLEY FT, BIANCHI A, HOFFBRAND AV, REITTIE JE, HESLOP HE, VYAKARNAM A, TURNER M, MEAGER A, BRENNER MK. Tumour necrosis factor as an autocrine tumour growth factor for chronic B-cell malignancies. Lancet 1998;1:969-971.
15. FOURNIER S, RUBIO M, DELESPESSE G, SARFATI M. Role for low-affinity receptor for IgE (CD23) in normal and leukemic B-cell proliferation. Blood 1994;84:1881-1886.
16. FRANCIA DI CELLE P, MARIANI S, RIERA L, STACCHINI A, REATO G, FOA R. Interleukin-8 induces the accumulation of B-cell chronic lymphocytic leukemia cells by prolonging survival in an autocrine fashion. Blood 1996;87:4382-4389.
17. GHIA P, STROLA G, GRANZIERO L, et al. Chronic lymphocytic leukemia B cells are endowed with the capacity to attract CD4+, CD40L+ T cells by producing CCL22. Eur J Immunol 2002;32:1403-1413.
18. MOSER B, LOETSCHER P. Lymphocyte traffic control by chemokines. Nat Immunol 2001;2:123-128.
19. LUSTER AD. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-445.
20. BURGER JA, BURGER M, KIPPS TJ. Chronic lymphocytic leukemia B cells express functional CXCR4 chemokine receptors that mediate spontaneous migration beneath bone marrow stromal cells. Blood 1999;94:3658-3667.
21. MAEDA A, BANDOBASHI K, NAGY N, TERAMOTO N, GOGOLAK P, POKROVSKAJA K, SZEKELY L, BJORKHOLM M, KLEIN G, KLEIN E. Epstein-Barr virus can infect B-chronic lymphocytic leukemia cells but it does not orchestrate the cell cycle regulatory proteins. J Hum Virol 2001;4:227-237.
22. STEWART JP, BEHM FG, ARRAND JR, ROONEY CM. Differential expression of viral and human interleukin-10 (IL-10) by primary B cell tumors and B cell lines. Virology 1994;200:724-732.
23. HENKART PA. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity 1994;1:343-346.
24. KOJIMA H, SHINOHARA N, HANAOKA S, et al. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity 1994;1:357-364.
25. MULLIGAN SP, DAO LP, FRANCIS SE, THOMAS ME, GIBSON J, COLE-SINCLAIR MF, WOLF M. B-cell chronic lymphocytic leukaemia with CD8 expression: report of 10 cases and immunochemical analysis of the CD8 antigen. Br J Haematol 1998;103:157-162.
26. VILPO J, KOSKI T, VILPO L. Calcium antagonists potentiate P-glycoprotein-independent anticancer drugs in chronic lymphocytic leukemia cells in vitro. Haematologica 2000;85:806-813.
27. SVOBODA-BEUSSAN I, KUSEC R, BENDELJA K, TUDORIC-GHEMO I, JAKSIC B, PEJSA V, RABATIC S, VITALE B. The relevance of multidrug resistance-associated P-glycoprotein expression in the treatment response of B-cell chronic lymphocytic leukemia. Haematologica 2000;85:1261-1267.
28. JUSZCZYNSKI P, NIEWIAROWSKI W, KRYKOWSKI E, ROBAK T, WARZOCHA K. Expression of the multidrug resistance-associated protein (mrp) gene in chronic lymphocytic leukemia. Leuk Lymphoma 2002;43:153-158.
29. CALIGARIS-CAPPIO F, HAMBLIN TJ. B-cell chronic lymphocytic leukemia: a bird of a different feather. J Clin Oncol 1999;17:399-408.
30. KLEIN U, TU Y, STOLOVITZKY GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 2001;194:1625-1638.